Certara Inc (CERT) Stock Analysis

Sector: HEALTHCARE - HEALTH INFORMATION SERVICES

Exchange: NASDAQ

Key Metrics

• Price: $6.80
• Market Cap: $1.05B
• P/E Ratio: 94.14
• EPS: $0.07
• 52-Week High: $15.38
• 52-Week Low: $6.32

Market Sentiment

Certara Inc currently has a Neutral sentiment score of 0.11.

About Certara Inc

Certara Inc. (CERT) is a prominent provider of biosimulation software and technology services designed to enhance the efficiency of drug discovery, preclinical and clinical research, and regulatory compliance. Headquartered in Princeton, New Jersey, the company utilizes advanced modeling and simulation techniques to empower pharmaceutical companies in making data-driven decisions that facilitate faster market access for new therapies. With a steadfast commitment to innovation, Certara is dedi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Certara Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CERT pay dividends?

Certara Inc (CERT) does not currently pay a regular dividend.

What is CERT's P/E ratio?

Certara Inc has a price-to-earnings (P/E) ratio of 94.14.

What is CERT's market cap?

Certara Inc (CERT) has a market capitalization of $1.05B with a current stock price of $6.80.